Anesthesia gases such as nitrous oxide, xenon, and desflurane are used in medical procedures that require anesthesia to block the perception of pain and consciousness. These gases are administered to patients under controlled conditions by anesthesia delivery equipment or anesthesia machines during surgeries and other medical procedures. The global anesthesia gases market is witnessing significant growth owing to rising incidence of chronic illnesses and an increasing number of surgeries performed worldwide.
The global anesthesia gases market is estimated to be valued at US$ 2182.32 million in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends: One of the key trends driving the growth of the anesthesia gases market is the increasing application opportunities in hospitals and ambulatory surgical centers. These facilities are increasingly adopting anesthesia gases due to their advantages such as quick induction and emergence times as well as precise delivery through advanced anesthesia delivery equipment. Moreover, anesthesia gases allow for minimal post-operative recovery times and contribute to enhancing patient comfort during medical procedures. The growing demand for surgical procedures in ambulatory surgical centers and hospitals will further augment the application of anesthesia gases during the forecast period.
Segment Analysis
The global anesthesia gases market is segmented based on product type, application, and region. Based on product type, the market is segmented into nitrous oxide, desflurane, sevoflurane, isoflurane, and others. The nitrous oxide segment dominates the market as it is widely used as an analgesic during surgical procedures. Moreover, nitrous oxide is known to offer rapid induction and recovery, making it preferable over other gases.
Key Takeaways
The global anesthesia gases market demand is expected to witness high growth over the forecast period of 2024 to 2031. The global anesthesia gases market is estimated to be valued at US$ 2182.32 million in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Regional analysis:
North America currently dominates the anesthesia gases market and is expected to maintain its position over the forecast period. This is attributed to the growing prevalence of chronic diseases and rising number of surgeries in the region. Furthermore, presence of key market players and early adoption of technologically advanced medical devices and equipment also contributes to market growth in North America.
Key players: Key players operating in the anesthesia gases market are Abbott, Baxter, AbbVie, B. Braun Melsungen AG, Halocarbon Products Corporation, Fresenius Kabi, and others. Abbott leads the anesthesia gases market and offers a wide range of anesthesia gas delivery machines and vaporizers. The company continues to strengthen its market position through strategic acquisitions and product launches.
Get more insights on this topic: https://www.newswirestats.com/anesthesia-gases-market-industry-insights-trends-anesthesia-gases-market/
Comments
0 comment